An imperfect world: assessing safety of biological treatments in systemic lupus erythematosus. Comment on the article by Materne et al. (2024)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.42689
PubMed Identifier: 37653671
Publication URI: http://europepmc.org/abstract/MED/37653671
Type: Journal Article/Review
Volume: 76
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 2
ISSN: 2326-5191